거즈 붕대 롤 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the gauze bandage rolls was valued at USD 2.02 billion in 2025 and estimated to grow from USD 2.13 billion in 2026 to reach USD 2.78 billion by 2031, at a CAGR of 5.47% during the forecast period (2026-2031). This report is Segmented by Material Type (Cotton Gauze Rolls, Woven Gauze Rolls, Elastic Gauze Rolls, and More), Application (Surgical Wounds, Chronic Wounds, and More), End User (Hospitals, Ambulatory Surgical Centers, and More), Distribution Channel (Direct Tenders & GPOs, Retail Pharmacies, and More), and Geography (North America, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Gauze Bandage Rolls Market Trends and Insights

Surging Volume of Minimally-Invasive & Robotic Surgeries

Robot-assisted procedures create small incisions that demand gauze with low fiber-shedding and heightened absorption to protect precision surgical fields. Radiopaque yarns enable surgeons and AI-driven imaging systems to confirm removal before closure, lowering retained-sponge events. Hospital supply managers now treat advanced gauze as a regulated device, requiring validated performance data before purchase. As more robotic cases migrate to outpatient centers, procurement teams favor premium formulations that accelerate recovery under limited clinical supervision. The result is sustained demand for specialty products across the Gauze Bandage Rolls market, even as surgical technology itself becomes more sophisticated.

Rapid Growth of Outpatient/ASC Wound Closures

Ambulatory surgical centers (ASCs) prioritize dressings that limit post-op visits and empower patient self-management. Gauze engineered for extended wear and moisture control therefore wins contracts when total cost of care-rather than acquisition price-guides purchasing. Clinical directors increasingly evaluate dressings on their ability to maintain comfort scores and reduce unplanned consultations, shifting gauze from a commodity to a quality-metric lever. Manufacturers that supply outcome data gain an edge in the Gauze Bandage Rolls market because many ASCs now include dressing performance in accreditation audits.

Substitution by Advanced Hydrocolloid & Foam Dressings

Foam dressings achieve superior moisture balance and reduce change frequency, often shortening healing time versus traditional gauze. When nursing labor is accounted for, total cost can favor foam even at higher unit prices, prompting formulary switches in chronic-wound clinics. Manufacturers of gauze respond by adding antimicrobial coatings or hydrogel layers, yet the performance gap persists in heavily exuding wounds. Institutional shift toward value-based reimbursement therefore moderates volume expansion in the Gauze Bandage Rolls market.

Other drivers and restraints analyzed in the detailed report include:

1. Government Bulk-Buy Programs in China & India Driving Tender Sizes
2. Re-Shoring of U.S./EU Medical-Textile Supply Chains Post-COVID
3. Cotton Price Volatility Squeezing Margins

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Cotton rolls held 46.02% of 2025 revenue, validating their entrenched clinical acceptance and low unit cost. Antimicrobial and impregnated gauze-often carrying silver, PHMB, or honey-are scaling fastest at 9.05% CAGR, reflecting infection-control mandates in acute and post-acute care. The Gauze Bandage Rolls market size for these enhanced products is expected to more than double by 2030, encouraging R&D investment. Non-woven viscose and polyester blends gain traction in orthopedic theaters because they shed fewer fibers, lowering risk of granuloma formation. Elastic rolls sustain niche demand in compression therapy, while X-ray detectable variants remain surgical staples.

Competitive differentiation now centers on absorption kinetics, bacterial-kill profiles, and imaging compatibility rather than mere thread count. Regulatory pathways have tightened accordingly: manufacturers must supply bench and in-vivo data to secure 510(k) clearances in the United States or CE marking in Europe. Smaller firms often out-license coating technologies to scale quickly, while multinationals vertically integrate cotton supply to mitigate raw-material risk. As a result, the Gauze Bandage Rolls market witnesses a convergence of textile engineering and pharmaceutical know-how.

Surgical wounds generated 51.12% of 2025 revenue, maintained by standardized use across operating rooms worldwide. Meticulous count protocols and the need for radiopaque markers reinforce gauze consumption per procedure, sustaining high baseline volumes. Yet chronic wounds-diabetic foot ulcers, venous leg ulcers, pressure injuries-show the quickest expansion at 7.42% CAGR, as population aging and diabetes prevalence climb. The Gauze Bandage Rolls market size for chronic-care applications benefits from home-health expansion, where caregivers favor familiar, low-cost dressings augmented with antimicrobial agents.

Trauma and burn units continue to rely on high-absorbency gauze for rapid exudate management before specialized dressings are applied. Dental and ENT clinics require smaller, hemophilic sponges that conform to cavity shapes; these micro-niche formats spur custom manufacturing runs. Veterinary practitioners increasingly adopt human-grade gauze to treat companion animals, contributing incremental volume. Across applications, payer scrutiny pressures clinicians to document dressing impact on healing timelines, elevating the importance of published evidence within the Gauze Bandage Rolls market.

Complete Report Scope:

• By Material Type
  • Cotton Gauze Rolls
  • Non-woven Viscose/Poly Gauze Rolls
  • Woven Gauze Rolls
  • Elastic Gauze Rolls
  • Antimicrobial/Impregnated Gauze Rolls
  • X-ray Detectable Gauze Rolls
• By Application
  • Surgical Wounds
  • Chronic Wounds
  • Trauma & Burns
  • Dental & ENT Procedures
  • Veterinary Care
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics & Specialty Centres
  • Home Healthcare
  • Veterinary Facilities
  • Military & Field Hospitals
• By Distribution Channel
  • Direct Tenders & GPOs
  • Distributor / Wholesaler
  • Retail Pharmacies
  • Online Pharmacies
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 37.25% of 2025 revenue, reflecting robust surgical volumes, early adoption of robotic systems, and premium reimbursement for innovative dressings. Post-pandemic policies rewarding domestic production grant price premiums to U.S. plants, partially offsetting higher wages. Canada's single-payer framework centralizes purchasing, pushing suppliers to show quality metrics alongside competitive pricing, while Mexico's healthcare reform fosters new hospital builds that favor cost-efficient cotton-based products. Altogether these dynamics preserve the region's central role in the Gauze Bandage Rolls market.

Asia-Pacific leads growth at a projected 10.1% CAGR to 2031 as China and India expand universal health coverage. China's volume-price procurement contracts standardize antimicrobial criteria, driving scale in mid-tier product categories. Indian state tenders mirror the approach, but segment pricing tiers encourage separate SKUs for public and private buyers. Mature markets such as Japan and South Korea emphasize regulatory compliance and environmental packaging mandates, encouraging suppliers to invest in lifecycle assessments. ASEAN nations, meanwhile, prioritize affordability, creating a bifurcated Gauze Bandage Rolls market that rewards both global giants and agile domestic firms.

Europe records steady expansion anchored in sustainability mandates. The forthcoming EU Packaging and Packaging Waste Regulation compels gauze producers to incorporate recycled content and design recyclable wraps by 2026. Germany and the United Kingdom spearhead adoption of advanced dressings for chronic wounds, leveraging evidence-based guidelines. Southern European countries, operating under tighter fiscal constraints, continue to prioritize low-cost cotton rolls, sustaining volume in the Gauze Bandage Rolls market. East-European accession funds upgrade hospital infrastructure, producing incremental demand that global and regional suppliers court through joint-venture plants.

1. Solventum Corporation
2. Cardinal Health
3. Medline Industries
4. BSN medical (Essity)
5. Johnson & Johnson
6. Smiths Group
7. Molnlycke Health Care
8. McKesson Medical-Surgical
9. Hartmann Group
10. Dynarex Corp.
11. Convatec
12. Deroyal Industries
13. Lohmann & Rauscher
14. Winner Medical
15. TROGE Medical
16. Kuteks
17. Integrity Medical Devices
18. Neomedic Ltd.
19. Fazzini
20. Shandong Yuyun Sanhe
21. Zhende Medical

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Surging Volume Of Minimally-Invasive & Robotic Surgeries
  • 4.2.2 Rapid Growth Of Outpatient/ASC Wound Closures
  • 4.2.3 Government Bulk-Buy Programs In China & India Driving Tender Sizes
  • 4.2.4 Re-Shoring Of U.S./EU Medical-Textile Supply Chains Post-COVID
  • 4.2.5 Emergence Of Radiopaque Gauze Rolls For AI-Enabled Post-Op Imaging
  • 4.2.6 Increasing Battlefield Trauma Kits Across NATO & QUAD Forces
• 4.3 Market Restraints
  • 4.3.1 Substitution By Advanced Hydrocolloid & Foam Dressings
  • 4.3.2 Cotton Price Volatility Squeezing Margins
  • 4.3.3 Single-Use-Plastic Clamp Downs Hitting Synthetic Woven Gauze Adoption
  • 4.3.4 Decentralised 3-D Printed Dressings In Large Idns (Integrated-Delivery-Networks)
• 4.4 Porter's Five Forces
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Material Type
  • 5.1.1 Cotton Gauze Rolls
  • 5.1.2 Non-woven Viscose/Poly Gauze Rolls
  • 5.1.3 Woven Gauze Rolls
  • 5.1.4 Elastic Gauze Rolls
  • 5.1.5 Antimicrobial/Impregnated Gauze Rolls
  • 5.1.6 X-ray Detectable Gauze Rolls
• 5.2 By Application
  • 5.2.1 Surgical Wounds
  • 5.2.2 Chronic Wounds
  • 5.2.3 Trauma & Burns
  • 5.2.4 Dental & ENT Procedures
  • 5.2.5 Veterinary Care
• 5.3 By End User
  • 5.3.1 Hospitals
  • 5.3.2 Ambulatory Surgical Centers
  • 5.3.3 Clinics & Specialty Centres
  • 5.3.4 Home Healthcare
  • 5.3.5 Veterinary Facilities
  • 5.3.6 Military & Field Hospitals
• 5.4 By Distribution Channel
  • 5.4.1 Direct Tenders & GPOs
  • 5.4.2 Distributor / Wholesaler
  • 5.4.3 Retail Pharmacies
  • 5.4.4 Online Pharmacies
• 5.5 Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Solventum Corporation
  • 6.3.2 Cardinal Health
  • 6.3.3 Medline Industries
  • 6.3.4 BSN medical (Essity)
  • 6.3.5 Johnson & Johnson (Ethicon)
  • 6.3.6 Smith & Nephew
  • 6.3.7 Molnlycke Health Care
  • 6.3.8 McKesson Medical-Surgical
  • 6.3.9 Hartmann Group
  • 6.3.10 Dynarex Corp.
  • 6.3.11 ConvaTec Group
  • 6.3.12 Deroyal Industries
  • 6.3.13 Lohmann & Rauscher
  • 6.3.14 Winner Medical
  • 6.3.15 TROGE Medical
  • 6.3.16 Kuteks AS
  • 6.3.17 Integrity Medical Devices
  • 6.3.18 Neomedic Ltd.
  • 6.3.19 Fazzini Srl
  • 6.3.20 Shandong Yuyun Sanhe
  • 6.3.21 Zhende Medical

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment